OpenAI is considering a major investment in Merge Labs, a brain-computer interface startup targeting an $850 million valuation. Sam Altman is set to cofound Merge Labs with CEO Alex Bania, although he will not personally invest. This venture aligns with advances in AI to enhance BCI technology, paralleling Elon Musk's initiatives with Neuralink. Altman's interests in BCIs trace back to 2017 when he speculated on the convergence of humans and machines. Both Altman and Musk continue to pursue similar aspirations in technology despite past conflicts.
OpenAI is weighing a significant investment in Merge Labs, a BCI startup aiming for an $850 million valuation with the aid of its ventures team.
Altman is expected to assist in launching Merge Labs but will not invest his own money, despite being named a cofounder.
Merge Labs plans to use AI advancements for creating better BCIs, aligning with Musk’s vision at Neuralink.
Both Altman and Musk share ambitions for brain-machine interfaces, stemming from their early interests in merging humans with machines.
Collection
[
|
...
]